SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-064057
Filing Date
2023-08-07
Accepted
2023-08-07 16:05:30
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_inmunebio.htm   iXBRL 10-Q 507735
2 CERTIFICATION f10q0623ex31-1_inmunebio.htm EX-31.1 10288
3 CERTIFICATION f10q0623ex31-2_inmunebio.htm EX-31.2 10498
4 CERTIFICATION f10q0623ex32-1_inmunebio.htm EX-32.1 4374
5 CERTIFICATION f10q0623ex32-2_inmunebio.htm EX-32.2 4339
  Complete submission text file 0001213900-23-064057.txt   3596372

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20230630.xsd EX-101.SCH 50668
7 XBRL CALCULATION FILE inmb-20230630_cal.xml EX-101.CAL 29202
8 XBRL DEFINITION FILE inmb-20230630_def.xml EX-101.DEF 191620
9 XBRL LABEL FILE inmb-20230630_lab.xml EX-101.LAB 414060
10 XBRL PRESENTATION FILE inmb-20230630_pre.xml EX-101.PRE 202567
57 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_inmunebio_htm.xml XML 317715
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 231147575
SIC: 2836 Biological Products, (No Diagnostic Substances)